Inspire Medical Systems (INSP) Free Cash Flow Growth (3y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 6.28% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 9.63% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 22.80% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 29.36% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -27.72% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -0.27% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 77.20% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -20.37% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.32% |
| 10 | Inspire Medical Systems | 1.17 Bn | 889.44 Mn | 176.91 Mn | 37.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37.73% |
| Dec 31, 2025 | 31.38% |
| Sep 30, 2025 | 124.94% |
| Jun 30, 2025 | 26.58% |
| Mar 31, 2025 | 10.61% |
| Dec 31, 2024 | 147.01% |
| Sep 30, 2024 | 234.39% |
| Jun 30, 2024 | 28.63% |
| Mar 31, 2024 | 31.81% |
| Dec 31, 2023 | 58.19% |
| Sep 30, 2023 | 30.83% |
| Jun 30, 2023 | 26.19% |
| Mar 31, 2023 | 30.26% |
| Dec 31, 2022 | 101.48% |
| Sep 30, 2022 | 52.03% |
| Jun 30, 2022 | 24.53% |
| Mar 31, 2022 | -7.57% |
| Dec 31, 2021 | 54.01% |
| Sep 30, 2021 | 25.17% |
| Jun 30, 2021 | -23.94% |
| Mar 31, 2021 | -22.19% |
| Dec 31, 2020 | -12.18% |
| Sep 30, 2020 | -46.03% |
| Jun 30, 2020 | -85.02% |
| Mar 31, 2020 | -39.25% |